Searchable abstracts of presentations at key conferences in endocrinology

ea0020p350 | Diabetes and Cardiovascular | ECE2009

Mildronate positively affects compensation of diabetes in streptozotocin rats and alters iNOS gene expression in rat tissues

Sokolovska Jelizaveta , Kalvinsh Ivars , Sharipova Jelena , Lauberte Lasma , Sjakste Nikolajs

Mildronate, a γ-butyrobetaine analogue is actually used as an antiischemic drug. It was also shown to have effect on mechanisms of glucose utilization.Methods: Diabetes mellitus in Wistar rats was induced by injection of streptozotocin (50 mg/kg). Experimental rats were treatment with Mildronate (100 mg/kg daily, per os) for 6 weeks. Weight, blood glucose concentration, blood triglyceride concentration, blood ketone body concentration, glycat...

ea0026p696 | Diabetes complications | ECE2011

Changes in GLUT1 expression under metformin treatment in rat models of severe and mild stretozotocin diabetes mellitus

Sokolovska Jelizaveta , Isajevs Sergejs , Sugoka Olga , Sharipova Jelena , Lauberte Lasma , Svirina Darja , Rostoka Evita , Sjakste Tatjana , Kalvinsh Ivars , Sjakste Nikolajs

Introduction: Metformin improves hyperglycaemia via mechanisms which include activation of AMP-activated protein kinase (AMPK). Recent findings indicate that some metabolic actions of metformin occur also by AMPK-independent mechanisms.Objective: To study the action of metformin on expression of GLUT1 glucose transporter in rat models of severe and mild stretozotocin diabetes mellitus.Materials and methods: Severe diabetes mellitus...